NCT05086315
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05086315
Title First-in-human Study of SAR443579 Infusion in Male and Female Participants of at Least 12 Years of Age With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL) or High Risk-myelodysplasia (HR-MDS)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA | NLD | FRA | AUS

Facility Status City State Zip Country Details
City of Hope-Site Number:8400002 Duarte California 91010 United States Details
Emory University School of Medicine- Grady Campus- Site Number : 8400006 Atlanta Georgia 30303 United States Details
Beth Israel Deaconess Medical Center-Site Number:8400004 Boston Massachusetts 02215 United States Details
Weill Cornell Medical College-Site Number:8400003 New York New York 10021 United States Details
Montefiore Hutchinson Campus- Site Number : 8400012 The Bronx New York 10461 United States Details
The Ohio State University- Site Number : 8400009 Columbus Ohio 43210 United States Details
Oregon Health and Science University-Site Number:8400011 Portland Oregon 97239 United States Details
Children's Hospital of Philadelphia-3401 Civic Center Blvd Site Number : 8400013 Philadelphia Pennsylvania 19104-4318 United States Details
The Children's Hospital of Philadelphia- Site Number : 8400013 Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center-Site Number:8400001 Houston Texas 77030 United States Details
Seattle Children's Hospital- Site Number : 8400014 Seattle Washington 98105 United States Details
Investigational Site Number :0360002 Melbourne Victoria 3000 Australia Details
Investigational Site Number :0360001 Melbourne Victoria 3004 Australia Details
Investigational Site Number : 1560001 Tianjin 300020 China Details
Investigational Site Number : 1560003 Zhengzhou 450008 China Details
Investigational Site Number :2500002 Marseille 13009 France Details
Investigational Site Number :2500001 Paris 75010 France Details
Investigational Site Number : 2500004 Paris 75019 France Details
Investigational Site Number :2500003 Villejuif 94800 France Details
Investigational Site Number :5280002 Amsterdam 1081 HV Netherlands Details
Investigational Site Number :5280003 Groningen 9713 GZ Netherlands Details
Investigational Site Number : 5280005 Nijmegen 6525 GA Netherlands Details
Investigational Site Number :5280001 Rotterdam 3015 CE Netherlands Details
Investigational Site Number :5280004 Utrecht 3584 CS Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field